Association of Blood Glucose Variability with Sepsis-Related Disseminated Intravascular Coagulation Morbidity and Mortality

References

• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801–810. doi:10.1001/jama.2016.0287
   PubMed Web of Science ®Google Scholar
• van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017;17:407–420. doi:10.1038/nri.2017.36
   PubMed Web of Science ®Google Scholar
• Jackson SP, Darbousset R, Schoenwaelder SM. Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms. Blood. 2019;133:906–918. doi:10.1182/blood-2018-11-882993
   PubMed Web of Science ®Google Scholar
• van der Poll T, Herwald H. The coagulation system and its function in early immune defense. Thromb Haemost. 2014;112:640–648. doi:10.1160/TH14-01-0053
   PubMed Web of Science ®Google Scholar
• Giustozzi M, Ehrlinder H, Bongiovanni D, et al. Coagulopathy and sepsis: pathophysiology, clinical manifestations and treatment. Blood Rev. 2021;50:100864. doi:10.1016/j.blre.2021.100864
   PubMed Web of Science ®Google Scholar
• Gando S, Saitoh D, Ogura H, et al. A multicenter, prospective validation study of the Japanese Association for Acute Medicine disseminated intravascular coagulation scoring system in patients with severe sepsis. Crit Care. 2013;17:R111. doi:10.1186/cc12783
   PubMed Web of Science ®Google Scholar
• Dhainaut JF, Yan SB, Joyce DE, et al. Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost. 2004;2:1924–1933. doi:10.1111/j.1538-7836.2004.00955.x
   PubMed Web of Science ®Google Scholar
• Kienast J, Juers M, Wiedermann CJ, et al. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost. 2006;4:90–97. doi:10.1111/j.1538-7836.2005.01697.x
   PubMed Web of Science ®Google Scholar
• Wolfe RR, Allsop JR, Burke JF. Glucose metabolism in man: responses to intravenous glucose infusion. Metabolism. 1979;28:210–220. doi:10.1016/0026-0495(79)90066-0
   PubMed Web of Science ®Google Scholar
• Shangraw RE, Jahoor F, Miyoshi H, et al. Differentiation between septic and postburn insulin resistance. Metabolism. 1989;38:983–989. doi:10.1016/0026-0495(89)
   PubMed Web of Science ®Google Scholar
• Robinson LE, van Soeren MH. Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control. AACN Clin Issues. 2004;15:45–62. doi:10.1097/00044067-200401000-00004
   PubMedGoogle Scholar
• Coursin DB, Connery LE, Ketzler JT. Perioperative diabetic and hyperglycemic management issues. Crit Care Med. 2004;32:S116–25. doi:10.1097/01.ccm.0000115623.52021.c0
   PubMed Web of Science ®Google Scholar
• Malmberg K, Rydén L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57–65. doi:10.1016/0735-1097(95)00126-k
   PubMed Web of Science ®Google Scholar
• Malmberg K; DIGAMI (diabetes mellitus, insulin glucose infusion in acute myocardial infarction) Study Group. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ. 1997;314:1512–1515. doi:10.1136/bmj.314.7093.1512
   PubMed Web of Science ®Google Scholar
• Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125–139. doi:10.1056/NEJMoa070716
   PubMed Web of Science ®Google Scholar
• Devos P. Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the Glu Control study. Intensive Care Med. 2007;33:S189.
   Google Scholar
• Agus MS, Steil GM, Wypij D, et al. Tight glycemic control versus standard care after pediatric cardiac surgery. N Engl J Med. 2012;367:1208–1219. doi:10.1056/NEJMoa1206044
   PubMed Web of Science ®Google Scholar
• Schultz MJ, Spronk PE, van Braam Houckgeest F. Glucontrol, no control, or out of control? Intensive Care Med. 2010;36:173–4;author reply 175. doi:10.1007/s00134-009-1666-2
   PubMed Web of Science ®Google Scholar
• Finfer S, Chittock DR, Su SY, et al.; NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–1297. doi:10.1056/NEJMoa0810625
   PubMed Web of Science ®Google Scholar
• Kauffmann RM, Hayes RM, Buske BD, et al. Increasing blood glucose variability heralds hypoglycemia in the critically ill. J Surg Res. 2011;170(2):257–264. doi:10.1016/j.jss.2011.03.008
   PubMed Web of Science ®Google Scholar
• Hirsch IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications. 2005;19:178–181. doi:10.1016/j.jdiacomp.2004.10.001
   PubMed Web of Science ®Google Scholar
• Brownlee M, Hirsch IB. Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA. 2006;295:1707–1708. doi:10.1001/jama.295.14.1707
   PubMed Web of Science ®Google Scholar
• Hirsch IB. Glycemic variability and diabetes complications: does it matter? Of course it does! Diabetes Care. 2015;38:1610–1614. doi:10.2337/dc14-2898
   PubMed Web of Science ®Google Scholar
• DeVries JH. Glucose variability: where it is important and how to measure it. Diabetes. 2013;62:1405–1408. doi:10.2337/db12-1610
   PubMed Web of Science ®Google Scholar
• Siegelaar SE, Holleman F, Hoekstra JB, DeVries JH. Glucose variability; does it matter? Endocr Rev. 2010;31:171–182. doi:10.1210/er.2009-0021
   PubMed Web of Science ®Google Scholar
• Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med. 2008;36:3008–3013. doi:10.1097/CCM.0b013e31818b38d2
   PubMed Web of Science ®Google Scholar
• Zhou J, Li H, Ran XY, et al. Establishment of normal reference ranges for glycemic variability in Chinese subjects using continuous glucose monitoring. Med Sci Monit. 2011;17:CR9–C13. doi:10.12659/msm.881318
   PubMed Web of Science ®Google Scholar
• Klimontov VV, Saik OV, Korbut AI. Glucose variability: how does it work? Int J Mol Sci. 2021;22:7783. doi:10.3390/ijms22157783
   PubMed Web of Science ®Google Scholar
• Kovatchev B, Cobelli C. Glucose variability: timing, risk analysis, and relationship to hypoglycemia in diabetes. Diabetes Care. 2016;39:502–510. doi:10.2337/dc15-2035
   PubMed Web of Science ®Google Scholar
• Hermanides J, Vriesendorp TM, Bosman RJ, Zandstra DF, Hoekstra JB, Devries JH. Glucose variability is associated with intensive care unit mortality. Crit Care Med. 2010;38:838–842. doi:10.1097/CCM.0b013e3181cc4be9
   PubMed Web of Science ®Google Scholar
• Preechasuk L, Suwansaksri N, Ipichart N, Vannasaeng S, Permpikul C, Sriwijitkamol A. Hyperglycemia and glycemic variability are associated with the severity of sepsis in nondiabetic subjects. J Crit Care. 2017;38:319–323. doi:10.1016/j.jcrc.2016.12.005
   PubMed Web of Science ®Google Scholar
• Silveira LM, Basile-Filho A, Nicolini EA, Dessotte CAM, Aguiar GCS, Stabile AM. Glycaemic variability in patients with severe sepsis or septic shock admitted to an Intensive Care Unit. Intensive Crit Care Nurs. 2017;41:98–103. doi:10.1016/j.iccn.2017.01.004
   PubMed Web of Science ®Google Scholar
• Pitrowsky M, Shinotsuka CR, Soares M, Salluh JI. Glucose control in critically ill patients in 2009: no alarms and no surprises. Rev Bras Ter Intensiva. 2009;21:310–314.
   PubMedGoogle Scholar
• Waeschle RM, Moerer O, Hilgers R, Herrmann P, Neumann P, Quintel M. The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability. Crit Care. 2008;12:R129. doi:10.1186/cc7097
   PubMed Web of Science ®Google Scholar
• Kanamori T, Takeshita Y, Isobe Y, et al. Mealtime dosing of a rapid-acting insulin analog reduces glucose variability and suppresses daytime cardiac sympathetic activity: a randomized controlled study in hospitalized patients with type 2 diabetes. BMJ Open Diabetes Res Care. 2018;6:e000588. doi:10.1136/bmjdrc-2018-000588
   PubMed Web of Science ®Google Scholar
• Higgins SJ, De Ceunynck K, Kellum JA, et al. Tie2 protects the vasculature against thrombus formation in systemic inflammation. J Clin Invest. 2018;128:1471–1484. doi:10.1172/JCI97488
   PubMed Web of Science ®Google Scholar
• Wang M, Kou H, Deng J, et al. Retrospective evaluation of new Chinese diagnostic scoring system for disseminated intravascular coagulation. PLoS One. 2015;10:e0129170. doi:10.1371/journal.pone.0129170
   PubMed Web of Science ®Google Scholar
• Fan YW, Liu D, Chen JM, Li WJ, Gao CJ. Fluctuation in red cell distribution width predicts disseminated intravascular coagulation morbidity and mortality in sepsis: a retrospective single-center study. Minerva Anestesiol. 2021;87:52–64. doi:10.23736/S0375-9393.20.14420-1
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 15. Diabetes care in the hospital: standards of medical care in Diabetes-2021. Diabetes Care. 2021;44:S211–20. doi:10.2337/dc21-S015
   PubMed Web of Science ®Google Scholar
• Rodbard D. Glucose variability: a review of clinical applications and research developments. Diabetes Technol Ther. 2018;20:S25–S215. doi:10.1089/dia.2018.0092
   PubMed Web of Science ®Google Scholar
• Mesejo A, Montejo-González JC, Vaquerizo-Alonso C, et al. Diabetes-specific enteral nutrition formula in hyperglycemic, mechanically ventilated, critically ill patients: a prospective, open-label, blind-randomized, multicenter study. Crit Care. 2015;19:390. doi:10.1186/s13054-015-1108-1
   PubMed Web of Science ®Google Scholar
• Zuo YY, Kang Y, Yin WH, Wang B, Chen Y. The association of mean glucose level and glucose variability with intensive care unit mortality in patients with severe acute pancreatitis. J Crit Care. 2012;27:146–152. doi:10.1016/j.jcrc.2011.12.004
   PubMed Web of Science ®Google Scholar
• Ryan EA, Shandro T, Green K, et al. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes. 2004;53:955–962. doi:10.2337/diabetes.53.4.955
   PubMed Web of Science ®Google Scholar
• Berry SD, Ngo L, Samelson EJ, Kiel DP. Competing risk of death: an important consideration in studies of older adults. J Am Geriatr Soc. 2010;58:783–787. doi:10.1111/j.1532-5415.2010.02767.x
   PubMed Web of Science ®Google Scholar
• Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLOS Med. 2007;4:e297. doi:10.1371/journal.pmed.0040297
   PubMed Web of Science ®Google Scholar
• Ali NA, O’Brien JM, Dungan K, et al. Glucose variability and mortality in patients with sepsis. Crit Care Med. 2008;36:2316–2321. doi:10.1097/CCM.0b013e3181810378
   PubMed Web of Science ®Google Scholar
• Bateman RM, Sharpe MD, Jagger JE, et al. 36th International Symposium on intensive care and emergency medicine: Brussels, Belgium. Crit Care. 2016;20;(Suppl 2):94.
   PubMed Web of Science ®Google Scholar
• Gando S, Levi M, Toh CH. Disseminated intravascular coagulation. Nat Rev Dis Primers. 2016;2:16037. doi:10.1038/nrdp.2016.37
   PubMed Web of Science ®Google Scholar
• Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med. 2010;38:S26–S34. doi:10.1097/CCM.0b013e3181c98d21
   PubMed Web of Science ®Google Scholar
• Caliezi C, Wuillemin WA, Zeerleder S, Redondo M, Eisele B, Hack CE. C1-esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Pharmacol Rev. 2000;52:91–112.
   PubMed Web of Science ®Google Scholar
• Bone RC. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med. 1996;24:163–172. doi:10.1097/00003246-199601000-00026
   PubMed Web of Science ®Google Scholar
• Fico G, Hernández L, Cancela J, et al. Exploring the frequency domain of continuous glucose monitoring signals to improve characterization of glucose variability and of diabetic profiles. J Diabetes Sci Technol. 2017;11:773–779. doi:10.1177/1932296816685717
   PubMedGoogle Scholar
• Thomsen RW, Hundborg HH, Lervang HH, Johnsen SP, Schønheyder HC, Sørensen HT. Diabetes mellitus as a risk and prognostic factor for community-acquired bacteremia due to enterobacteria: a 10-year, population-based study among adults. Clin Infect Dis. 2005;40:628–631. doi:10.1086/427699
   PubMed Web of Science ®Google Scholar
• Stegenga ME, Vincent JL, Vail GM, et al. Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis. Crit Care Med. 2010;38:539–545. doi:10.1097/CCM.0b013e3181c02726
   PubMed Web of Science ®Google Scholar
• Esper AM, Moss M, Martin GS. The effect of diabetes mellitus on organ dysfunction with sepsis: an epidemiological study. Crit Care. 2009;13:R18. doi:10.1186/cc7717
   PubMed Web of Science ®Google Scholar
• Graham BB, Keniston A, Gajic O, Trillo Alvarez CA, Medvedev S, Douglas IS. Diabetes mellitus does not adversely affect outcomes from a critical illness. Crit Care Med. 2010;38:16–24. doi:10.1097/CCM.0b013e3181b9eaa5
   PubMed Web of Science ®Google Scholar
• Schuetz P, Jones AE, Howell MD, et al. Diabetes is not associated with increased mortality in emergency department patients with sepsis. Ann Emerg Med. 2011;58:438–444. doi:10.1016/j.annemergmed.2011.03.052
   PubMed Web of Science ®Google Scholar
• Bellomo R, Egi M. Hypoglycemia in sepsis: biomarker, mediator, or both? Crit Care Med. 2011;39:2367–2369. doi:10.1097/CCM.0b013e31822a5be5
   PubMed Web of Science ®Google Scholar
• Ssekitoleko R, Jacob ST, Banura P, et al. Hypoglycemia at admission is associated with inhospital mortality in Ugandan patients with severe sepsis. Crit Care Med. 2011;39:2271–2276. doi:10.1097/CCM.0b013e3182227bd2
   PubMed Web of Science ®Google Scholar
• Finfer S, Liu B, Chittock DR, et al.; NICE-SUGAR Study Investigators. Hypoglycemia and risk of death in critically ill patients. N Engl J Med. 2012;367:1108–1118. doi:10.1056/NEJMoa1204942
   PubMed Web of Science ®Google Scholar
• D’Ancona G, Bertuzzi F, Sacchi L, et al. Iatrogenic hypoglycemia secondary to tight glucose control is an independent determinant for mortality and cardiac morbidity. Eur J Cardiothorac Surg. 2011;40:360–366. doi:10.1016/j.ejcts.2010.11.065
   PubMed Web of Science ®Google Scholar
• Umpierrez G, Cardona S, Pasquel F, et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary artery bypass graft surgery: GLUCO-CABG trial. Diabetes Care. 2015;38:1665–1672. doi:10.2337/dc15-0303
   PubMed Web of Science ®Google Scholar
• See KC. Glycemic targets in critically ill adults: a mini-review. World J Diabetes. 2021;12:1719–1730. doi:10.4239/wjd.v12.i10.1719
   PubMed Web of Science ®Google Scholar
• Tateishi K, Saito Y, Kitahara H, Kobayashi Y. Impact of glycemic variability on coronary and peripheral endothelial dysfunction in patients with coronary artery disease. J Cardiol. 2022;79:65–70. doi:10.1016/j.jjcc.2021.08.009
   PubMed Web of Science ®Google Scholar
• Farabi SS, Quinn L, Phillips S, et al. Endothelial dysfunction is related to glycemic variability and quality and duration of sleep in adults with Type 1 diabetes. J Cardiovasc Nurs. 2018;33:E21–5–e5. doi:10.1097/JCN.0000000000000485
   Web of Science ®Google Scholar
• Cosenso-Martin LN, Takaoka LY, Vilela-Martin JF. Randomized study comparing vildagliptin vs glibenclamide on glucose variability and endothelial function in patients with type 2 diabetes mellitus and hypertension. Diabetes Metab Syndr Obes. 2020;13:3221–3229. doi:10.2147/DMSO.S257096
   PubMed Web of Science ®Google Scholar
• Ito T, Kakuuchi M, Maruyama I. Endotheliopathy in septic conditions: mechanistic insight into intravascular coagulation. Crit Care. 2021;25:95. doi:10.1186/s13054-021-03524-6
   PubMed Web of Science ®Google Scholar
• Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181–1247. doi:10.1007/s00134-021-06506-y
   PubMed Web of Science ®Google Scholar